Pricing Log in Create free account

Acumen Pharmaceuticals, Inc. (ABOS) vs Spruce Biosciences, Inc. (SPRB)

Acumen Pharmaceuticals, Inc. and Spruce Biosciences, Inc. are both Biotechnology companies. Acumen Pharmaceuticals, Inc. and Spruce Biosciences, Inc. are of similar size ($120.8M and $119.2M). Across the 12 metrics below, Spruce Biosciences, Inc. leads on 9 and Acumen Pharmaceuticals, Inc. on 3.

Valuation

Metric ABOS SPRB Biotechnology median
P/E n/m n/m 8.50
P/S 85.03 19.63 9.71
P/B 2.13 1.15 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 30.28 1.46 9.21
Earnings yield (96.45%) (100.33%) (33.15%)
Free cash flow yield (75.24%) (44.38%) (25.50%)

Profitability

Metric ABOS SPRB Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (120.50%) (105.98%) (56.36%)
Return on assets (72.97%) (82.38%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABOS SPRB Biotechnology median
Revenue growth (TTM) — (51.32%) 6.02%
EPS growth (last fiscal year) (16.96%) 47.59% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABOS SPRB Biotechnology median
Debt to equity 0.55 0.08 0.00
Current ratio 2.47 9.23 4.72
Net debt to EBITDA 0.69 1.34 0.96

Dividend

Metric ABOS SPRB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABOS SPRB Biotechnology median
Market cap 120.77m 119.19m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack